COVID-19 Triggered CAD, Muscle Inflammation in Leukemia Patient, Report Says

COVID-19 Triggered CAD, Muscle Inflammation in Leukemia Patient, Report Says

292053

COVID-19 Triggered CAD, Muscle Inflammation in Leukemia Patient, Report Says

A woman developed cold agglutinin disease (CAD) and myositis (muscle inflammation) as a complication of COVID-19, underscoring the importance of a timely, comprehensive evaluation to identify rare complications of SARS-CoV-2 infection. Researchers noted that the patient’s history of leukemia and treatment with tirabrutinib, a medication that blocks abnormal immune cell activity in cancer and autoimmune diseases, may have played a role in the development of these disorders.  More study is “required to ascertain the relation…

You must be logged in to read/download the full post.